Grasso Marc's most recent trade in Kyverna Therapeutics Inc. was a trade of 450,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics Inc | Marc Grasso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 02 Jun 2025 | 16,488 | 296,072 (0%) | 0% | 1.3 | 22,068 | Common Stock |
| Alector Inc | Marc Grasso | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.47 per share. | 03 Mar 2025 | 18,091 | 312,560 (0%) | 0% | 1.5 | 26,547 | Common Stock |
| Alector Inc | Grasso Marc | Chief Financial Officer | 02 Dec 2024 | 16,489 | 330,651 (0%) | 0% | 2.5 | 41,542 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 01 Oct 2024 | 216,400 | 347,140 (0%) | 0% | 0 | Common Stock | ||
| Alector Inc | Marc Grasso | Chief Financial Officer | 03 Sep 2024 | 7,297 | 130,740 (0%) | 0% | 4.9 | 35,620 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 03 Jun 2024 | 6,920 | 138,037 (0%) | 0% | 4.8 | 33,208 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 04 Mar 2024 | 5,716 | 144,957 (0%) | 0% | 6.9 | 39,562 | Common Stock | |
| Alector Inc | Grasso Marc | Chief Financial Officer | 04 Dec 2023 | 4,574 | 150,673 (0%) | 0% | 5.6 | 25,431 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 02 Jun 2023 | 1,050 | 33,361 (0%) | 0% | 6.9 | 7,249 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 02 Mar 2023 | 1,291 | 34,411 (0%) | 0% | 8.3 | 10,739 | Common Stock | |
| Alector Inc | Marc Grasso | Chief Financial Officer | 01 Oct 2022 | 35,702 | 35,702 (0%) | 0% | 0 | Common Stock | ||
| Alector Inc | Marc Grasso | Chief Financial Officer | 01 Oct 2022 | 23,801 | 23,801 | - | - | Employee Stock Option (right to buy) | ||
| Alector Inc | Marc Grasso | Chief Financial Officer | 01 Mar 2022 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | ||
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 131,000 | 131,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Marc Grasso | CFO, CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,900 | 21,900 (0%) | 0% | 0 | Common Stock |